HeHe welcomes Zhenya Lindgardt, President and CEO of Sera Prognostics, to discuss the critical issue of preterm birth, its rising incidence in the U.S., and innovative solutions available today. Zhenya explains the definition and statistics of preterm birth, and introduces the Preterm test, a blood test that predicts the risk of preterm birth as early as 18 weeks of gestation. The conversation also covers the effectiveness of Sera Prognostics' intervention bundles, improvements in pregnancy care, and the importance of innovation in maternal health. Listeners will learn about the accessibility and process of the Preterm test and the overall goal of making this technology widely available to improve maternal and neonatal outcomes.
Understanding Preterm Birth
Advancements in Preterm Birth Testing
Interventions for High-Risk Pregnancies
Clinical Trials and Results
At-Home Testing and Accessibility
Innovation in Maternal Health
Guest Bio:
Zhenya Lindgardt is an accomplished leader in healthcare innovation, currently serving as the President, CEO, and Board Director of Sera Prognostics, Inc. and CEO of The Commons Project Foundation. As the leader of Sera, Zhenya is revolutionizing the maternal and infant health space by addressing the preterm birth crisis with cutting-edge science. With a rich background including senior roles at Uber Technologies and a 19-year tenure at Boston Consulting Group, she has demonstrated expertise in driving growth and fostering innovation. Her contributions span multiple therapeutic areas and focus on leveraging data to improve patient outcomes and reduce healthcare costs.
INSTAGRAM:
https://www.facebook.com/serapregnancy
https://www.instagram.com/serathepregnancycompany?igsh=NTc4MTIwNjQ2YQ==
https://www.linkedin.com/company/sera-prognostics
BIRTH EDUCATION:
Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience!
Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone!
Websites:
PreTRM® Premature Birth Risk Blood Test from Sera
NYU article about racial disparities in pre-term birth rates
What is causing the rise in pre-term birth?
Diagnostics:
AVERT Trial Press Release: Sera PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial | Sera
AVERT Trial Data: https://www.mdpi.com/2075-4418/14/14/1462
